miR-25 Promotes Cardiomyocyte Proliferation by Targeting FBXW7
2020 · Molecular Therapy — Nucleic Acids · 32 citations
https://doi.org/10.1016/j.omtn.2020.01.013
F
Fujian Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
852
Citations
16
h-index
19
i10-index
Fujian Wu is an academic researcher from Victor Chang Cardiac Research Institute. The author has contributed to research in topics: Pluripotent Stem Cells Research & CRISPR and Genetic Engineering & Neuroscience and Neural Engineering. The author has an h-index of 16, co-authored 35 publications.
ORCID: 0000-0003-0291-3236Papers by this author
worksMircroRNA-10b Promotes Human Embryonic Stem Cell-Derived Cardiomyocyte Proliferation via Novel Target Gene LATS1
2019 · Molecular Therapy — Nucleic Acids · 23 citations
https://doi.org/10.1016/j.omtn.2019.11.026
hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
2021 · Stem Cell Research & Therapy · 18 citations
https://doi.org/10.1186/s13287-021-02346-1
Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system
2020 · Stem Cell Research · 14 citations
https://doi.org/10.1016/j.scr.2020.101930
Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system
2021 · Stem Cell Research · 3 citations
https://doi.org/10.1016/j.scr.2020.102152
Establishment of human embryonic stem cell WAe009-A-48 carrying a long QT syndrome mutation in SCN5A
2021 · Stem Cell Research · 0 citations
https://doi.org/10.1016/j.scr.2021.102194
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat